B
QTTB icon

Bailard’s Q32 Bio QTTB Stock Holding History

Bailard’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,319
Closed -$47K – 772
2022
Q2 		$47K Buy
+1,319
New +$45K ﹤0.01% 673

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bailard's QTTB Position: Q3 2022 in Review

Bailard sold out of Q32 Bio (QTTB) in Q3 2022, closing a stake of 1,319 shares — an estimated $47K sold.

Bailard first reported a position in QTTB in Q2 2022 and held it in 1 quarter. The position peaked at $47K in Q2 2022. 83 funds tracked by Wall St. Rank hold QTTB as of Q3 2022.

  • Bailard reported no remaining Q32 Bio position as of Q3 2022 after selling out during the quarter.
  • Bailard sold 1,319 Q32 Bio shares in Q3 2022, an estimated $47K.
  • Bailard first reported a position in Q32 Bio in Q2 2022 and held it in 1 quarter.
  • Bailard's Q32 Bio position peaked at $47K in Q2 2022.
  • 83 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2022.

Based on Bailard's 13F filing for Q3 2022, filed 18 Oct 2022.